Vulvar Cancer at Dr. Soetomo Regional General Hospital in 2024
International Journal of Drug Delivery Technology · 29.06.2026 · 16 (59s)
DOI: 10.25258/ijddt.16.59s.34 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.06.2026. Verfasst von Elisabeth Getrudis Kunigunda Liga und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Vulvar cancer is a rare gynecologic malignancy that primarily affects postmenopausal women, with squamous cell carcinoma being the most common histological subtype. This study aims to describe the clinical characteristics, histopathological findings, and treatment patterns of vulvar cancer patients treated at Dr. Soetomo Regional General Hospital, Surabaya, Indonesia, during the year 2024. A retrospective descriptive study was conducted on all patients diagnosed with vulvar cancer at the hospital's gynecologic oncology division. Data were collected from medical records including age at diagnosis, clinical presentation, histopathological type, tumor stage, and treatment modalities. The findings provide valuable insights into the burden and management of vulvar cancer in a major tertiary referral hospital in Eastern Indonesia, highlighting the need for early detection and improved access to specialized care.
Zitieren
APA
Liga, E. G. K., & Tjokroprawiro, B. A. (2026). Vulvar Cancer at Dr. Soetomo Regional General Hospital in 2024. International Journal of Drug Delivery Technology, 16(59s). https://doi.org/10.25258/ijddt.16.59s.34
Vancouver
Liga EGK, Tjokroprawiro BA. Vulvar Cancer at Dr. Soetomo Regional General Hospital in 2024. International Journal of Drug Delivery Technology. 2026;16(59s). doi:10.25258/ijddt.16.59s.34
BibTeX
@article{Liga2026,
author = {Liga, Elisabeth Getrudis Kunigunda and Tjokroprawiro, Brahmana Askandar},
title = {Vulvar Cancer at Dr. Soetomo Regional General Hospital in 2024},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {59s},
doi = {10.25258/ijddt.16.59s.34}
}
EUVIMED